Tg(Thy1-APP*)2Tbay
Transgene Detail
|
Symbol: |
Tg(Thy1-APP*)2Tbay |
Name: |
transgene insertion 2, Thomas A Bayer |
MGI ID: |
MGI:6343355 |
Synonyms: |
Tg4-42, Tg(Thy1-Trh/Abeta*)2Tbay |
Transgene: |
Tg(Thy1-APP*)2Tbay Location: unknown
|
Alliance: |
Tg(Thy1-APP*)2Tbay page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Thy1-APP*)2Tbay expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
Human APP expressing a truncated (aa 4-42) protein |
|
|
|
Mutation details: The 7.2kb kb Tg4-42 transgene is designed with the Thy1 promoter driving expression of human Abeta 4-42 fused to a murine thyrotropin releasing hormone signal peptide. Transgenic mice express an N-truncated Abeta 4-42< (amino acids 4-42), a peptide shown to enhance Abeta aggregation in the brains of Alzheimer's disease (AD) patients. Founder line 2 has the highest expression of the transgene and sontains more than 20 copies in head-to-tail orientation, with the last transgene in reverse orientation.
(J:275188)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:275188 Bouter Y, et al., N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Acta Neuropathol. 2013 Aug;126(2):189-205 |
All: |
13 reference(s) |
|